MedPath

The diagnostic ability for hepatic steatosis using ultrasound attenuation imaging as reference standerd MRI-PDFF, liver tissue and controlled attenuation parameter(CAP); a prospective multicenter study.

Not Applicable
Conditions
chronic liver disease
Registration Number
JPRN-UMIN000048672
Lead Sponsor
Hyogo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

In patients who underwent MRI-PDFF, patients with claustrophobia patients with magnetic substance or tattoo patients with pacemakers Patients judged as inappropriate for the study by the study responsibility (share) physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The diagnostic ability for the hepatic steatosis using ultrasound attenuation imaging
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath